N-terminal mid-region osteocalcin

Biomarker

1 paper1 finding

  • Human trial1

Interventions

1

Liraglutide

upin humans1

1 study
  1. Liraglutide increases N-terminal mid-region osteocalcin in humans.

    Human trialin type 2 diabetes mellitus, combined with metformin48 weeksmales

    EFFECTS OF LIRAGLUTIDE ON BONE TURNOVER MARKERS AND BONE MINERAL DENSITY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

    Acta endocrinologica (Bucharest, Romania : 2005)1 Apr 2025

More on Liraglutide

Latest